Vaishali Pharma Receives NSE Approval To List 45.38 Lakh Preferential Shares

NSE granted in-principle approval to list 45,37,865 equity shares of ₹2 each allotted on a preferential basis. Trading will commence after NSDL/CDSL confirm credit to beneficiary accounts, adding dilution to Vaishali Pharma’s listed share base.